Phibro Animal Health Expands Portfolio with Zoetis Acquisition
Company Announcements

Phibro Animal Health Expands Portfolio with Zoetis Acquisition

An update from Phibro Animal Health ( (PAHC) ) is now available.

Phibro Animal Health Corporation has acquired Zoetis Inc.’s medicated feed additives and water-soluble products for $350 million, marking a major step in enhancing its global animal health and nutrition capabilities. This acquisition, featuring over 37 product lines and a presence in around 80 countries, is expected to boost Phibro’s profitability and expand its product offerings across cattle, swine, and poultry sectors. The deal is anticipated to diversify Phibro’s revenue base and support future investments in the fast-growing animal health industry.

For a thorough assessment of PAHC stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyPhibro Animal Health initiated with a Neutral at JPMorgan
TheFlyPhibro Animal Health price target raised to $15 from $13 at BofA
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App